Bio-Rad Laboratories (BIO) Income from Non-Controlling Interests (2009 - 2013)

Bio-Rad Laboratories' (BIO) quarterly Income from Non-Controlling Interests came in at $21000.0 in Q1 2013, up 134.43% year-on-year from $8958.0 in Q1 2012, and up 126.58% on a QoQ basis from -$79000.0 in Q4 2012.

Bio-Rad Laboratories (BIO) Income from Non-Controlling Interests (2009 - 2013) Analysis & Trends

Bio-Rad Laboratories (BIO) has 5 years of Income from Non-Controlling Interests data on file, last reported at $21000.0 in Q1 2013.

  • On a quarterly basis, Income from Non-Controlling Interests rose 134.43% year-over-year to $21000.0 in Q1 2013; TTM through Dec 2013 was $21000.0, a 69.57% decrease from a year earlier, with the FY2013 full-year figure at $21000.0, down 69.57% from the prior year.
  • Income from Non-Controlling Interests for Q1 2013 stood at $21000.0, up from -$79000.0 in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for BIO reached as high as $776000.0 in Q3 2009 and fell as low as -$1.3 million in Q2 2009.
  • Historically, Income from Non-Controlling Interests has averaged $90000.0 across 5 years, with a median of $4000.0 in 2012.
  • Across the five-year window, Income from Non-Controlling Interests sank 231.03% in 2011 and soared 953.85% in 2012, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at $660000.0 in 2009, then slumped by 95.61% to $29000.0 in 2010, then sank by 231.03% to -$38000.0 in 2011, then sank by 107.89% to -$79000.0 in 2012, then jumped by 126.58% to $21000.0 in 2013.
  • Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $21000.0 in Q1 2013, -$79000.0 in Q4 2012, and -$13000.0 in Q3 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -5.85 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 22.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Bio-Rad Laboratories 8.53 Bn 6.97 Bn 309.40 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2013 21,000.00
Dec 31, 2012 -79,000.00
Sep 30, 2012 -13,000.00
Jun 30, 2012 222,000.00
Mar 31, 2012 -61,000.00
Dec 31, 2011 -38,000.00
Sep 30, 2011 -35,000.00
Jun 30, 2011 -26,000.00
Mar 31, 2011 -101,000.00
Dec 31, 2010 29,000.00
Sep 30, 2010 321,000.00
Jun 30, 2010 564,000.00
Mar 31, 2010 531,000.00
Dec 31, 2009 660,000.00
Sep 30, 2009 776,000.00
Jun 30, 2009 -1.33 Mn